Skip to Content
You are currently on the new version of our website. Access the old version .
ProceedingsProceedings
  • Abstract
  • Open Access

12 April 2024

2 Pages

In Silico Study of Combined Docking and Molecular Dynamics Simulation for Hops (Humulus lupulus) Active Compounds in Inhibiting Duffy-Binding Protein (DBP) as Anti-Plasmodium vivax (P. vivax) †

,
,
and
1
Department of Biochemistry, Faculty of Mathematics and Natural Sciences, IPB University, Bogor 16680, West Java, Indonesia
2
Bioinformatics Research Center, Indonesian Institute of Bioinformatics (INBIO Indonesia), Malang 65145, East Java, Indonesia
*
Author to whom correspondence should be addressed.
†
Presented at the 3rd International Electronic Conference on Biomolecules, 23–25 April 2024; Available online: https://sciforum.net/event/IECBM2024.

Abstract

Malaria is one of the infectious illnesses causing a public health burden worldwide. Plasmodium vivax (P. vivax) is the most prevalent malaria parasite in Asia and Asia Pacific. P. vivax is resistant to sulfadoxine–pyrimethamine (SP) and mefloquine. This resistance makes it extremely difficult to control and eradicate due to its ability to survive in the liver and reactivate if the person infected has a weakened immune system. Thus, this study aims to inhibit P. vivax via targeting Duffy-binding protein (DBP) with active compounds from Hops (Humulus lupulus). The inhibition of DBP is essential to reduce malaria invasion of human red blood cells. We performed a quality assessment and prediction of the active site of DBP to determine the effectiveness and prediction of ligands in inhibiting DBP. Furthermore, the mechanism and structural stability of active compounds against DBP were evaluated using a combination of molecular docking and molecular dynamics simulation and a density-functional theory (DFT) study. The results showed that rutin had the highest binding of 8.852 kcal/mol. However, after the molecular dynamics simulation was run for 50 ns, the ligand 6-prenylnaringenin via MM-PBSA calculation showed the most positive value of 106.760 kJ/mol. In addition, 6-prenylnaringenin is the most stable ligand via the analysis of root-mean-square deviation backbone (RMSDBb), root-mean-square deviation c-alpha (RMSDCa), root-mean-square fluctuation (RMSF), solvent-accessible surface area (SASA), radius of gyration (Rg), and the hydrogen bond formation. We conclude that 6-prenylnaringenin has a tight and stable bond with the targeted DBP protein. Finally, we propose the use of 6-prenylnaringenin as a potential antimalarial compound via in silico studies.

Author Contributions

Conceptualization, G.M.G. and R.A.P.I.; methodology, G.M.G., R.A.P.I. and M.A.D.; software, G.M.G. and R.A.P.I.; validation, G.M.G., R.A.P.I. and M.A.D.; formal analysis, G.M.G., R.A.P.I., M.A.D. and M.M.A.H.; investigation, G.M.G. and R.A.P.I.; resources, G.M.G., R.A.P.I., M.A.D. and M.M.A.H.; data curation, G.M.G. and R.A.P.I.; writing—original draft preparation, G.M.G. and M.A.D.; writing—review and editing, G.M.G., R.A.P.I., M.A.D. and M.M.A.H.; visualization, G.M.G. and R.A.P.I.; supervision, G.M.G.; project administration, G.M.G. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Data Availability Statement

The data that support the findings of this study are available from the corresponding author upon reasonable request.

Conflicts of Interest

The authors declare no conflicts of interest.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.